Central Labs

2008 Brochure


Download the Central Labs Conference Brochure

Customer Service

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200


Need Technical Assistance With this Website?
Send an email to IIR's Web Department

Day One

Day One

Tuesday January 27th, 2009
7:30Registration and Morning Coffee hosted by
8:15

Chairperson’s Welcome
Robert Scott-Edwards, President, ICON CENTRAL LABORATORIES

Cynthia Lindemann, Associate CDS Consultant/Central Laboratory Coordinator, Clinical Diagnostic Services, ELI LILLY & COMPANY

8:30Featured Session

The Changing Face of R&D: Trends in New Drug Development

How are economic, regulatory, and competitive forces changing the Ken Kaitinpharmaceutical landscape? What are researchbased companies doing to meet the growing demand for improved R&D efficiency and output? In what ways can outsourcing and offshoring stem the rising time, cost, and risk of drug development? Reporting on recent Tufts CSDD analyses, we will explore the current environment for pharmaceutical R&D and examine the impact of efforts to boost R&D performance.
Kenneth I. Kaitin, PhD, Director and Professor of Medicine, TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT
Risk Assessment
9:30Drug Safety Evaluation: Benefit-Risk Assessments throughout Development and Therapy
J. Rick Turner, PhD, Chairman, Department of Clinical Research, CAMPBELL UNIVERSITY SCHOOL OF PHARMACY
10:15Networking Break in Exhibit Hall
11:00

Improve Operational Success by Developing Vendor Quality Management Plans

Martie Griffin, VP of QA, CELTIC PHARMA
Marie V. Ulrich, Vendor Quality Manager, GLOBAL VENDOR QUALITY MANAGEMENT a division of Global Clinical Trial Logistics, WYETH RESEARCH
Rajani Prasad, PhD, Vice President, Clinical Research, CRL, CLINICAL REFERENCE LABORATORY

11:45Current and Future Metrics Champion Consortium Metrics Initiatives

Guy Mascaro, President, Metrics Champion Consortium, MCC
David Rauh, Clinical Diagnostic Services Imaging Management, ELI LILLY & COMPANY
Sue Hwang,  Senior Manager, R&D Global Strategic Sourcing, AMGEN
Steve Asbury, Global ECG Coordinator, ELI LILLY & COMPANY
12:15Strolling Networking Luncheon in Exhibit Hall
Track A: Central Lab Relationship Development
1:30Chairperson’s Opening Remarks
Clare O’Sullivan, General Manager, ICON Central Laboratories, Dublin
1:35Improve Patient Care, Transparency and Process Efficiency in Global Studies

Solomon Babani, Director, CELTIC PHARMA DEVELOPMENT SERVICES
Scott Sawicki, MA, Section Head, Central Laboratory & Diagnostic Services, CRO Management, NOVARTIS PHARMACEUTICALS CORPORATION
Stephanie Talbott, Vice President, Global Business Development, ICON CENTRAL LABORATORIES
Heidi Egelhoff, Manager, Business Development, UBC CLINICAL TECHNOLOGIES GROUP
2:00

Central Lab Cost Drivers and Logistics Discussion Forum

John Monetti, Vice President, Sales and Marketing, WORLD COURIER
Scott Sawicki, MA, Section Head, Central Laboratory & Diagnostic Services, CRO Management, NOVARTIS PHARMACEUTICALS CORPORATION
Rajani Prasad, PhD, Vice President, Clinical Research, CRL, CLINICAL REFERENCE LABORATORY
Mike Harvey, Managing Director of Operations, QUEST DIAGNOSTICS

2:30

Support of Local Laboratories by a Central Laboratory in Global Phase III Oncology Trials

Jaap H.M. Dijkman, MD, MBA, PPM, Senior Director, Business Development, COVANCE CENTRAL LABORATORY SERVICES

Dr. Marc-Ulrich Häusler, Senior Clinical Data Manager, Global Data Management, Merck Serono Development/Global Clinical Operations

3:00 -3:45Networking Break in Exhibit Hall Hosted by:
3:45Best Practices for Collecting and Integrating Data in International Clinical Trials

Jennifer Duff, Associate Director, ACCENTURE AT WYETH
Greg Burgess, Manager, External Data Aquisition Operations, SPRI
4:15Risk Management for Global Studies

Beth Sabatino, Outsourcing Manager, BRISTOL-MYERS SQUIBB
PANEL DISCUSSION
4:45Development of Central Laboratory in China- Challenges and Opportunities

Dr. James J Ho, MD, PhD, DABCC, Chief Executive Officer, PEKING UNION LAWKE BIOMEDICAL DEVELOPMENT LIMITED
5:15Tuesday Concludes
5:15-6:45Reception in Exhibit Hall Hosted by
Track B: Standardization in Imaging Studies
1:30Chairperson’s Opening Remarks

David Rauh, Clinical Diagnostic Services Imaging Management, ELI LILLY & COMPANY
1:35Current Standardization Initiatives for Use of Imaging in Clinical Trials

David Mozley, MD, Senior Director, MERCK & COMPANY
2:00MCC METRICS

Metrics Champion Consortium Imaging Performance Metrics Announcement


David Rauh, Clinical Diagnostic Services Imaging Management, ELI LILLY & COMPANY
2:30Utility of Imaging in Clinical Trials- Strategies for Success

Craig Lipset, Director, Molecular Medicine, PFIZER
P David Mozley, MD, Senior Director, MERCK & COMPANY
3:00 -3:45Networking Break in Exhibit Hall Hosted by:
PANEL DISCUSSION
3:45Bridging Small Imaging Studies to Large Imaging Studies for Smoother Transitions

Donald Cooper, Director Project Management, BIOMEDICAL SYSTEMS
George Mills, PdD, Vice President, Medical Imaging Consulting, PERCEPTIVE INFORMATICS
PANEL DISCUSSION & EXTENDED SESSION
4:15 Standardizing Intra/Inter Observer Variability and Adjudication Rates in Imaging Studies

David L. Raunig, PhD, Associate Director, Imaging Translational Technologies Statistics, PFIZER GLOBAL RESEARCH DEVELOPMENT
Jim Conklin, Senior Vice President, Medical Scientific Affairs, ICON MEDICAL IMAGING
Ed Ashton, Chief Scientific Officer, VIRTUAL SCOPICS
5:15Tuesday Concludes
5:15-6:45Reception in Exhibit Hall Hosted by
Track C: Improving and Standardizing ECG and Cardiac Safety Studies
1:30Chairperson’s Opening Remarks
Tim Callahan, PhD, Chief Scientific Officer, BIOMEDICAL SYSTEMS
1:35Update on FDA Guidance for ECG Related Studies

Jeffrey Litwin, MD, Chief Medical Officer & Executive Vice President, eRESEARCHTECHNOLOGY
2:00Improving and Standardizing ECG and Cardiac Safety Studies - ECG Data Integration
and Standardization with CDM/EDC Systems


Jane Gale, Principal, GALE-BENTZ CONSULTING
PANEL DISCUSSION
2:30New Equipment and Software Technology Landscape

Moderator:
Tim Callahan, PhD, Chief Scientific Officer, BIOMEDICAL SYSTEMS
Panelists:
Dr. Tosja K. Zywietz, CARDINAL HEALTH RESEARCH SERVICES
3:00 -3:45Networking Break in Exhibit Hall Hosted by:

 3:45

 Methods to Mitigate the Potentially Distorting Effect of Heart Rate in QT Analyses

Lawrence Z. Satin, MD, FACC, Chief Medical Officer, CARDIOCORE TBA SHIRE PHARMACEUTICALS
MCC METRICS
4:15Using the MCC ECG Metrics

Jeffrey Litwin, MD, Chief Medical Officer & Executive Vice President, eRESEARCHTECHNOLOGY
Steve Asbury, Global ECG Coordinator, ELI LILLY & COMPANY
PANEL DISCUSSION
4:45Hot Topics and Trends in Cardiac Safety Studies

Moderator:
Tim Callahan, PhD, Chief Scientific Officer, BIOMEDICAL SYSTEMS
Panelists:
Jay W. Mason, MD, Cardiac Safety Consultant, OBS MEDICAL
5:15Tuesday Concludes
5:15-6:45Reception in Exhibit Hall Hosted by
  
             
BROCHURE REGISTER  GET UPDATES  RECOMMEND CONTACT HOME    BACK TO TOP
©2008 IIR HOLDINGS, LTD. All Rights Reserved.